This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Methylprednisolone Does Not Reduce Odds of Poor Outcomes in Infant Heart Surgery

Friday, November 11, 2022

Submitted by


Erik Swain, Larry A. Allen, Richard Smith

According to results of the STRESS trial, infants undergoing heart surgery with cardiopulmonary bypass did not have a lower chance of a bad outcome when administered with the steroid methylprednisolone, compared to the placebo. This trial was part of an initiative to develop a more reliable method of conducting clinical trials involving pediatric heart surgery patients.

Add comment

Log in or register to post comments